Jyothy Laboratories reported a rise of 6.78 per cent in net sales at Rs 154.65 crore for the quarter ended September 30th, 2011, against Rs 144.82 crore in second quarter.
Net profit
Net profit for the quarter stood at Rs 12.49 crore against Rs 15.37 crore.
The EBIDTA for the quarter stood at Rs. 22.53 crore, against Rs 20.87 crore reported in the year ago period. JLL reported EPS of Rs 1.55, against Rs 2.01 in the corresponding quarter last year.
Henkel India (HIL), an 83.65 per cent subsidiary of Jyothy Laboratories Ltd has reported EBITDA of 10.59 per cent.
During the quarter, HIL's net sales stood at Rs 107.46 crore, against Rs 135.38 crore for the corresponding period last year.
During the quarter, HIL's net loss was Rs 2.76 crore, against loss of Rs 14.82 crore in the same period last year.
tough period for the company
In a press release Mr M. P. Ramachandran – Chairman and Managing Director, Jyothy Laboratories Ltd said, “ This quarter is an outcome of tough period for Jyothy with challenges like restructuring the distribution, alignment with Henkel distribution model, shifting to no credit policy, manoeuvring increasing costs, high inflation and the task of turning around Henkel operations. We are confident that these tough measures taken to improve the efficiency at all the levels will pave the way for sustained long term revenue and profit growth both at Jyothy and Henkel.”